Report Company Directory
- Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference by GlobeNewsWire
- Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx) by GlobeNewsWire
- Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences by GlobeNewsWire
- Axogen, Inc. Reports Third Quarter 2025 Financial Results by GlobeNewsWire
- Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025 by GlobeNewsWire
- Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences by GlobeNewsWire
- Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft by GlobeNewsWire
- Axogen, Inc. Reports Second Quarter 2025 Financial Results by GlobeNewsWire
- Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference by GlobeNewsWire
- Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025 by GlobeNewsWire